Chemistry:Bimokalner
From HandWiki
Bimokalner is an investigational new drug under evaluation for preventing and treating hearing loss caused by cisplatin treatment. It is a voltage-gated potassium channel agonist targeting Kv7.4 and is being developed by Acousia Therapeutics GmbH.[1][2]
References
- ↑ "Bimokalner". PatSnap. https://synapse.patsnap.com/drug/fe350648dddc4eb9a6868c9f58e61da7.
- ↑ "Age-related hearing loss: An updated and comprehensive review of the interventions". Iranian Journal of Basic Medical Sciences 27 (3): 256–269. 2024. doi:10.22038/IJBMS.2023.72863.15849. PMID 38333758.
 |  |
